United Therapeutics Corp reported $1.3B in net income in fiscal year 2025. This represents an increase of 11.7% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $1.2B in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters United Therapeutics Corp has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
UTHR Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.2B | $1.3B+11.7% | $1.2B+21.4% | $984.8M+35.4% | $727.3M+52.9% | $475.8M-7.6% | $514.8Mn/m | -$104.5M-117.7% | $589.2M+41.0% | $417.9M-41.4% | $713.7M+9.5% | $651.6M+91.6% | $340.1M+94.8% | $174.6M-42.7% | $304.4M+39.7% | $217.9M |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
UTHR Net Income by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More United Therapeutics Corp financials
Frequently Asked Questions
United Therapeutics Corp reported $1.3B in net income in fiscal year 2025.
United Therapeutics Corp (UTHR) net income rose by 11.7% year over year, from $1.2B to $1.3B in fiscal year 2025.
United Therapeutics Corp (UTHR) reported $1.2B in net income over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 15 fiscal years this page covers, United Therapeutics Corp (UTHR) net income went from $217.9M in fiscal year 2011 to $1.3B in fiscal year 2025.
United Therapeutics Corp (UTHR) reported $258.6M in net income in Q3 2026. This represents a decrease of 23.6% from the same quarter a year earlier.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what United Therapeutics Corp (UTHR) reported on that line in every period on record.